Ipilimumab vs Sacubitril-Valsartan
Ipilimumab vs Sacubitril-Valsartan: Overview
This comparison examines the pharmacological differences between Ipilimumab and Sacubitril-Valsartan.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Sacubitril-Valsartan: Angiotensin receptor-neprilysin inhibitor (ARNI) combining neprilysin inhibition with AT1 receptor blockade.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Sacubitril-Valsartan β 11.5 hours.
Chemical Properties
Molecular Formula: Sacubitril-Valsartan β C24H29N2O5.
Molecular Weight: Sacubitril-Valsartan β 414.5010 g/mol.
Type: Ipilimumab β Antibody; Sacubitril-Valsartan β Small molecule.